Chronic pain of neuropathic or inflammatory origins affects millions of sufferers in the United States for whom current therapies are inadequate. Because genetic factors significantly contribute to variability among individuals in prolonged pain sensitivity and susceptibility, gene mapping these traits will be useful for the determination of novel and predisposing genetic mechanisms in humans. Thus, this proposal will map the genes underlying variable susceptibility to partial nerve-injury induced hypersensitivity that mimics a common cause of neuropathic pain. Of the multiple pain responses to inflammation, only sensitivity to the immediate, spontaneous nociceptive response has been gene mapped. Thus, this proposal will map the genes under- lying prolonged inflammation-induced hypersensitivity. The genetic model of BXD recombinant inbred (Rl) mice will be used to perform quantitative trait locus (QTL) gene mapping of hypersensitivity to identify regions of the genome containing genes variants associated with variability in the traits.
The Specific Aims will test the hypothesis that the genetic mechanisms underlying these traits are distinct from those responsi- ble for all other classes of nociception and hypersensitivity, including all models previously gene mapped.
In Specific Aim 1, QTL gene mapping of mechanical sensitivity before, and of mechanical hypersensitivity (allodynia) after, ligation of the fifth lumbar nerve will be performed by surveying the sensitivity of 45 strains of Rl mice of known genotype. QTL mapping will proceed without further genotyping in this proposal due to the continually expanding publicly available genotype data for these mice.
In Specific Aim 2, QTL mapping will be similarly performed of spontaneous inflammatory nociception and thermal hypersensitivity following subcutaneous injection of melittin, the major algogenic and inflammatory component of honeybee venom. Due to the use of the BXD Rl mice with known, fixed genotype, single genetic mechanisms responsible for variability in the traits will be immediately determined in Specific Aim 3 by covariance analysis with transcript levels in the forebrain and other brain areas and tissues for which data already exist. In addition, sharing of genetic mechanisms between the hypersensitivity traits and previously studied pain traits and non-pain traits will be determined. These data will be used to determine novel genetic mechanisms of chronic neuropathic and inflammatory pain for predisposition assessment and treatment development.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Somatosensory and Chemosensory Systems Study Section (SCS)
Program Officer
Thomas, David A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Medicine
United States
Zip Code
Young, E E; Bryant, C D; Lee, S E et al. (2016) Systems genetic and pharmacological analysis identifies candidate genes underlying mechanosensation in the von Frey test. Genes Brain Behav 15:604-15
Young, Erin E; Costigan, Michael; Herbert, Teri A et al. (2014) Heritability of nociception IV: neuropathic pain assays are genetically distinct across methods of peripheral nerve injury. Pain 155:868-80
Henker, Richard A; Lewis, Allison; Dai, Feng et al. (2013) The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation. Biol Res Nurs 15:309-17
Belfer, Inna; Segall, Samantha K; Lariviere, William R et al. (2013) Pain modality- and sex-specific effects of COMT genetic functional variants. Pain 154:1368-76
Young, Erin E; Lariviere, William R; Belfer, Inna (2012) Genetic basis of pain variability: recent advances. J Med Genet 49:1-9
Philip, Vivek M; Sokoloff, Greta; Ackert-Bicknell, Cheryl L et al. (2011) Genetic analysis in the Collaborative Cross breeding population. Genome Res 21:1223-38
Mogil, Jeffrey S; Sorge, Robert E; LaCroix-Fralish, Michael L et al. (2011) Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction. Nat Neurosci 14:1569-73
Nair, Harsha K; Hain, Heather; Quock, Raymond M et al. (2011) Genomic loci and candidate genes underlying inflammatory nociception. Pain 152:599-606
Lariviere, William R; Mogil, Jeffrey S (2010) The genetics of pain and analgesia in laboratory animals. Methods Mol Biol 617:261-78
Chen, Jun; Lariviere, William R (2010) The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword. Prog Neurobiol 92:151-83

Showing the most recent 10 out of 12 publications